\-\ Texto\\:\\ \ \(0\)\
\-\ elevated\\ amylase\\,\\ lipase\\,\\ liver\\ associated\\ enzymes\\ and\\ bilirubin\ \(0\)\
\-\ on\\ ultrasound\\ imaging\\ the\\ patient\\ had\\ mild\\ gallbladder\\ wall\\ thickening\\ to\\ 4\\ mm\\ and\\ common\\ bile\\ duct\\ dilation\\ to\\ 9\\ mm\\.\\ neither\\ an\\ obstructing\\ lesion\\ nor\\ the\\ pancreas\\ was\\ visualized\\ on\\ ultrasound\\.\ \(0\)\
\-\ on\\ ct\\ scan\\ of\\ the\\ pancrease\\,\\ there\\ was\\ mild\\ gall\\ bladder\\ wall\\ thickening\\,\\ cbd\\ dilatation\\,\\ inflammatory\\ fat\\ stranding\\ around\\ the\\ pancreas\\ and\\ duodenal\\ small\\ bowel\\ and\\ a\\ circular\\ hyperdensity\\ in\\ the\\ distal\\ cbd\\.\ \(0\)\
\-\ gallstone\\ pancreatitis\ \(3\)\
\-\ following\\ ultrasound\\:\ \(0\)\
\-\ 1\\)\\ gallstone\ \(0\)\
\-\ 2\\)\\ tumor\\:\\ pancreatic\\,\\ cholangiocarcinoma\\,\\ ampullary\\/duodenal\\ carcinoma\\ or\\ metastasis\\.\ \(0\)\
\-\ 3\\)\\ benign\\ or\\ inflammatory\\ stricture\\.\ \(0\)\
\-\ 4\\)\\ iatrogenic\\ stricture\ \(1\)\
\-\ 5\\)\\ primary\\ sclerosing\\ cholangitis\\.\ \(0\)\
\-\ 6\\)\\ primary\\ biliary\\ cirrhosis\ \(0\)\
\-\ 7\\)\\ ascarasis\\ parasitic\\ obstruction\ \(0\)\
\-\ 74\\ yo\\ male\\ who\\ presented\\ to\\ the\\ er\\ with\\ a\\ three\\ day\\ history\\ of\\ progressive\\ epigastric\\ and\\ right\\ upper\\ quadrant\\ pain\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cbd\\:\\ 0\\.08921956135479023\ \(0\)\
\-\ gallstone\\:\\ 0\\.07523210871572647\ \(0\)\
\-\ stricture\\:\\ 0\\.060680952574427\ \(0\)\
\-\ pancrease\\:\\ 0\\.058380916715009924\ \(0\)\
\-\ ampullary\\/duodenal\\:\\ 0\\.058380916715009924\ \(0\)\
\-\ ascarasis\\:\\ 0\\.058380916715009924\ \(0\)\
\-\ pancreas\\:\\ 0\\.0579187704301481\ \(0\)\
\-\ ultrasound\\:\\ 0\\.05036667387429742\ \(0\)\
\-\ hyperdensity\\:\\ 0\\.04250081557064985\ \(0\)\
\-\ circular\\:\\ 0\\.041924581285950314\ \(0\)\
\-\ mm\\:\\ 0\\.04161847889794709\ \(0\)\
\-\ inflammatory\\:\\ 0\\.039249217803867864\ \(0\)\
\-\ thickening\\:\\ 0\\.038365888340309295\ \(0\)\
\-\ neither\\:\\ 0\\.03791043689144492\ \(0\)\
\-\ cholangitis\\:\\ 0\\.03733420260674538\ \(0\)\
\-\ gall\\:\\ 0\\.037063858272174156\ \(0\)\
\-\ enzymes\\:\\ 0\\.03680411844996699\ \(0\)\
\-\ cholangiocarcinoma\\:\\ 0\\.03563927959921425\ \(0\)\
\-\ parasitic\\:\\ 0\\.035027535757286996\ \(0\)\
\-\ amylase\\:\\ 0\\.034835565314417775\ \(0\)\
\-\ lipase\\:\\ 0\\.03464900321530059\ \(0\)\
\-\ iatrogenic\\:\\ 0\\.0344675530551144\ \(0\)\
\-\ bilirubin\\:\\ 0\\.0341189190585222\ \(0\)\
\-\ obstructing\\:\\ 0\\.03395125145597723\ \(0\)\
\-\ primary\\:\\ 0\\.033528268382724456\ \(0\)\
\-\ sclerosing\\:\\ 0\\.033472306677304206\ \(0\)\
\-\ cirrhosis\\:\\ 0\\.03332005821223998\ \(0\)\
\-\ epigastric\\:\\ 0\\.03317123135229257\ \(0\)\
\-\ \\)\\:\\ 0\\.033077906256908186\ \(0\)\
\-\ wall\\:\\ 0\\.03278356450647346\ \(0\)\
\-\ 74\\:\\ 0\\.0323423363658422\ \(0\)\
\-\ 4\\:\\ 0\\.031536051724225765\ \(0\)\
\-\ pancreatitis\\:\\ 0\\.031048900920009316\ \(0\)\
\-\ duodenal\\:\\ 0\\.0309429383945362\ \(0\)\
\-\ bile\\:\\ 0\\.03024518663521284\ \(0\)\
\-\ nor\\:\\ 0\\.03024518663521284\ \(0\)\
\-\ mild\\:\\ 0\\.029804681509021682\ \(0\)\
\-\ biliary\\:\\ 0\\.028580852673087638\ \(0\)\
\-\ pancreatic\\:\\ 0\\.027687347256535513\ \(0\)\
\-\ stranding\\:\\ 0\\.02737342514465085\ \(0\)\
\-\ gallbladder\\:\\ 0\\.027191974984464663\ \(0\)\
\-\ dilation\\:\\ 0\\.0266756733853275\ \(0\)\
\-\ duct\\:\\ 0\\.025944891549772097\ \(0\)\
\-\ dilatation\\:\\ 0\\.02425315781105112\ \(0\)\
\-\ around\\:\\ 0\\.023563066569130577\ \(0\)\
\-\ 9\\:\\ 0\\.023392812551182186\ \(0\)\
\-\ bladder\\:\\ 0\\.022969608564563107\ \(0\)\
\-\ visualized\\:\\ 0\\.022906835425791295\ \(0\)\
\-\ progressive\\:\\ 0\\.022367146457240417\ \(0\)\
\-\ er\\:\\ 0\\.02170982885396001\ \(0\)\
\-\ 7\\:\\ 0\\.02168380714442432\ \(0\)\
\-\ metastasis\\:\\ 0\\.021183757127814083\ \(0\)\
\-\ obstruction\\:\\ 0\\.019956291712512817\ \(0\)\
\-\ quadrant\\:\\ 0\\.01991639691381493\ \(0\)\
\-\ benign\\:\\ 0\\.01953013488101458\ \(0\)\
\-\ liver\\:\\ 0\\.019511400733991546\ \(0\)\
\-\ elevated\\:\\ 0\\.019200770605026906\ \(0\)\
\-\ three\\:\\ 0\\.019076981644681527\ \(0\)\
\-\ day\\:\\ 0\\.01796662138644324\ \(0\)\
\-\ bowel\\:\\ 0\\.01774803664162092\ \(0\)\
\-\ fat\\:\\ 0\\.017211339886633332\ \(0\)\
\-\ yo\\:\\ 0\\.01702881803511763\ \(0\)\
\-\ 6\\:\\ 0\\.01690145802235016\ \(0\)\
\-\ 5\\:\\ 0\\.01655735379102095\ \(0\)\
\-\ following\\:\\ 0\\.016061442098683102\ \(0\)\
\-\ carcinoma\\:\\ 0\\.01603925609282031\ \(0\)\
\-\ scan\\:\\ 0\\.015842857353860783\ \(0\)\
\-\ presented\\:\\ 0\\.015426209503459664\ \(0\)\
\-\ distal\\:\\ 0\\.015385950920172363\ \(0\)\
\-\ \\:\\:\\ 0\\.014970527364114769\ \(0\)\
\-\ common\\:\\ 0\\.014809716635472828\ \(0\)\
\-\ who\\:\\ 0\\.014754757676435113\ \(0\)\
\-\ on\\:\\ 0\\.01438194064302175\ \(0\)\
\-\ upper\\:\\ 0\\.013656162287210056\ \(0\)\
\-\ 1\\:\\ 0\\.013465737536157\ \(0\)\
\-\ associated\\:\\ 0\\.01335405670137551\ \(0\)\
\-\ or\\:\\ 0\\.013265201973029238\ \(0\)\
\-\ imaging\\:\\ 0\\.013258767049374853\ \(0\)\
\-\ 3\\:\\ 0\\.013251493554347946\ \(0\)\
\-\ tumor\\:\\ 0\\.013193591401396101\ \(0\)\
\-\ was\\:\\ 0\\.013089768506141547\ \(0\)\
\-\ small\\:\\ 0\\.01303692241311999\ \(0\)\
\-\ \\,\\:\\ 0\\.01254947323590074\ \(0\)\
\-\ had\\:\\ 0\\.012210925955236478\ \(0\)\
\-\ 2\\:\\ 0\\.012186122493447325\ \(0\)\
\-\ lesion\\:\\ 0\\.011526855801327514\ \(0\)\
\-\ male\\:\\ 0\\.010233149257532935\ \(0\)\
\-\ to\\:\\ 0\\.008484796856483172\ \(0\)\
\-\ there\\:\\ 0\\.008421957327582707\ \(0\)\
\-\ ct\\:\\ 0\\.00791591823438439\ \(0\)\
\-\ an\\:\\ 0\\.007825595127713443\ \(0\)\
\-\ history\\:\\ 0\\.007815990315940949\ \(0\)\
\-\ pain\\:\\ 0\\.00691131236775321\ \(0\)\
\-\ right\\:\\ 0\\.005971070921261037\ \(0\)\
\-\ and\\:\\ 0\\.0059605631037158435\ \(0\)\
\-\ patient\\:\\ 0\\.005672794244479391\ \(0\)\
\-\ the\\:\\ 0\\.005493349061071224\ \(0\)\
\-\ a\\:\\ 0\\.005252977507531143\ \(0\)\
\-\ in\\:\\ 0\\.002790710133379172\ \(0\)\
\-\ \\.\\:\\ 0\\.001645673858817377\ \(0\)\
\-\ of\\:\\ 0\\.001543096699311105\ \(0\)\
\-\ with\\:\\ 0\\.000774862093310528\ \(0\)\
